Prograf-Advagraf Cross Over Conversion Study

NCT01797341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Kidney-Pancreas Transplantation

Interventions

DRUG: Tacrolimus
DRUG: Tacrolimus

Sponsor

University Health Network, Toronto